Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 5
2001 4
2002 3
2003 3
2004 3
2005 6
2006 4
2007 2
2008 9
2009 5
2010 4
2011 8
2012 10
2013 7
2014 12
2015 17
2016 17
2017 20
2018 11
2019 17
2020 15
2021 18
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

186 results
Results by year
Filters applied: . Clear all
Page 1
Current therapy of KRAS-mutant lung cancer.
Ghimessy A, Radeczky P, Laszlo V, Hegedus B, Renyi-Vamos F, Fillinger J, Klepetko W, Lang C, Dome B, Megyesfalvi Z. Ghimessy A, et al. Among authors: dome b. Cancer Metastasis Rev. 2020 Dec;39(4):1159-1177. doi: 10.1007/s10555-020-09903-9. Cancer Metastasis Rev. 2020. PMID: 32548736 Free PMC article. Review.
Down-regulation of A20 promotes immune escape of lung adenocarcinomas.
Breitenecker K, Homolya M, Luca AC, Lang V, Trenk C, Petroczi G, Mohrherr J, Horvath J, Moritsch S, Haas L, Kurnaeva M, Eferl R, Stoiber D, Moriggl R, Bilban M, Obenauf AC, Ferran C, Dome B, Laszlo V, Győrffy B, Dezso K, Moldvay J, Casanova E, Moll HP. Breitenecker K, et al. Among authors: dome b. Sci Transl Med. 2021 Jul 7;13(601):eabc3911. doi: 10.1126/scitranslmed.abc3911. Sci Transl Med. 2021. PMID: 34233950 Free PMC article.
[Therapeutic possibilities in KRAS-mutant lung adenocarcinoma].
Radeczky P, Ghimessy Á, Berta J, László V, Hegedűs B, Rényi-Vámos F, Fillinger J, Megyesfalvi Z, Döme B. Radeczky P, et al. Among authors: dome b. Magy Onkol. 2020 Sep 23;64(3):231-244. Epub 2020 Aug 6. Magy Onkol. 2020. PMID: 33196710 Free article. Review. Hungarian.
Molecular profiles of small cell lung cancer subtypes: therapeutic implications.
Schwendenwein A, Megyesfalvi Z, Barany N, Valko Z, Bugyik E, Lang C, Ferencz B, Paku S, Lantos A, Fillinger J, Rezeli M, Marko-Varga G, Bogos K, Galffy G, Renyi-Vamos F, Hoda MA, Klepetko W, Hoetzenecker K, Laszlo V, Dome B. Schwendenwein A, et al. Among authors: dome b. Mol Ther Oncolytics. 2021 Feb 6;20:470-483. doi: 10.1016/j.omto.2021.02.004. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33718595 Free PMC article. Review.
[Rationale of antiangiogenic therapy].
Tímár J, Paku S, Tóvári J, Döme B. Tímár J, et al. Among authors: dome b. Magy Onkol. 2006;50(2):141-51. Epub 2006 Aug 4. Magy Onkol. 2006. PMID: 16888678 Free article. Review. Hungarian.
Lung Transplant Patients on Kilimanjaro.
Gieszer B, Radeczky P, Farkas A, Csende K, Mészáros L, Török K, Fazekas L, Bogyó L, Agócs L, Kocsis Á, Varga J, Bartók T, Dancs T, Kormosoi Tóth K, Schönauer N, Madurka I, Elek J, Döme B, Rényi-Vámos F, Lang G, Jaksch P, Ghimessy ÁK. Gieszer B, et al. Among authors: dome b. Transplant Proc. 2019 May;51(4):1258-1262. doi: 10.1016/j.transproceed.2019.04.004. Transplant Proc. 2019. PMID: 31101210
Lung cancer in never smokers.
Torok S, Hegedus B, Laszlo V, Hoda MA, Ghanim B, Berger W, Klepetko W, Dome B, Ostoros G. Torok S, et al. Among authors: dome b. Future Oncol. 2011 Oct;7(10):1195-211. doi: 10.2217/fon.11.100. Future Oncol. 2011. PMID: 21992731 Free article. Review.
Afatinib restrains K-RAS-driven lung tumorigenesis.
Moll HP, Pranz K, Musteanu M, Grabner B, Hruschka N, Mohrherr J, Aigner P, Stiedl P, Brcic L, Laszlo V, Schramek D, Moriggl R, Eferl R, Moldvay J, Dezso K, Lopez-Casas PP, Stoiber D, Hidalgo M, Penninger J, Sibilia M, Győrffy B, Barbacid M, Dome B, Popper H, Casanova E. Moll HP, et al. Among authors: dome b. Sci Transl Med. 2018 Jun 20;10(446):eaao2301. doi: 10.1126/scitranslmed.aao2301. Sci Transl Med. 2018. PMID: 29925635 Free PMC article.
Antiangiogenic drugs and tyrosine kinases.
Tímár J, Döme B. Tímár J, et al. Among authors: dome b. Anticancer Agents Med Chem. 2008 Jun;8(5):462-9. doi: 10.2174/187152008784533035. Anticancer Agents Med Chem. 2008. PMID: 18537529 Review.
186 results